Market Quotes

2281 items in section

Republic Services Beats Profit Estimates Despite Revenue Miss

Republic Services reported a fourth-quarter net income of $545 million, exceeding analyst expectations for earnings per share even as total revenue fell slightly short of Wall Street forecasts. The waste management giant benefited from core organic growth in its recycling and waste segments, offsetting a minor dip in its environmental solutions business.

Devon Energy Outperforms Estimates Ahead of $21.5B Coterra Merger

Devon Energy reported a decline in fourth-quarter profit and revenue as the Oklahoma City-based producer prepares to finalize its $21.5 billion all-stock merger with Coterra Energy. Despite the year-over-year slip, the company’s adjusted earnings beat Wall Street expectations, bolstered by record-setting production levels in the Delaware Basin.

Leonardo DRS Joins Pentagon’s $151 Billion SHIELD Defense Program

Leonardo DRS has secured multiple contracts under the Missile Defense Agency’s (MDA) $151 billion SHIELD program, positioning the defense contractor to support critical homeland defense infrastructure. The awards, announced Tuesday, fall under the Scalable Homeland Innovative Enterprise Layered Defense framework, a massive indefinite-delivery/indefinite-quantity vehicle designed to modernize the U.S. response to evolving aerial threats.

Robinhood to Launch NYSE-Listed Fund for Private Market Access

Robinhood is set to debut its first private-markets fund on the New York Stock Exchange in the coming weeks, offering retail investors a direct path to high-growth startups. The Robinhood Ventures Fund I, trading as RVI, aims to break down the barriers that typically restrict late-stage private investments to institutional players and the ultra-wealthy.

FDA Approves Shield Therapeutics’ AccruFeR for Pediatric Use

The U.S. Food and Drug Administration has authorized Shield Therapeutics to market its oral iron treatment, AccruFeR, for children aged 10 and older. The decision, announced Tuesday, significantly expands the patient base for the London-based biopharmaceutical firm following the drug's initial adult clearance in 2019.

Robinhood to List Private-Market Fund on NYSE for Retail Investors

Robinhood is set to launch its first venture fund on the New York Stock Exchange in the coming weeks, offering retail investors a rare gateway into high-growth private companies. Trading under the ticker RVI, the Robinhood Ventures Fund I aims to dismantle the barriers that have historically kept individual traders out of the private equity space.

VisionWave Shares Surge on $10 Million Crypto Mining Deal

VisionWave shares rose Tuesday after the defense technology firm secured a $10 million agreement to develop a high-performance cryptocurrency mining platform. The deal, structured as a milestone-based program with an undisclosed third-party vendor, marks a strategic expansion for the company into digital asset infrastructure.

Wolfspeed Shares Surge on Appointment of New EMEA Sales Chief

Wolfspeed shares climbed 11% on Tuesday following the appointment of Stefan Steyerl as Vice President of Sales for the EMEA region. The veteran executive, who officially joins the silicon carbide specialist on March 1, is tasked with scaling the company’s market presence across Europe, the Middle East, and Africa as it pivots toward high-growth power electronics.

Harmony Biosciences Wins FDA Nod for Pediatric Cataplexy Drug

The U.S. Food and Drug Administration has approved Harmony Biosciences’ supplemental drug application for Wakix, expanding its use to treat cataplexy in pediatric patients aged six and older. The decision establishes the medication as the first non-scheduled treatment option available for both adults and children suffering from the sudden muscle weakness associated with narcolepsy.

Donnelley Financial Shares Surge on Q4 Revenue Rebound

Donnelley Financial Solutions (DFIN) saw its shares climb 12% on Tuesday after the regulatory software provider snapped a multi-quarter losing streak with fourth-quarter revenue and earnings that significantly outpaced Wall Street estimates.

Oil Prices Retreat as U.S.-Iran Nuclear Talks Signal Progress

Crude oil and refined product futures slid on Tuesday following reports that high-level negotiations between the U.S. and Iran have established a framework for a potential nuclear deal. The prospect of easing geopolitical tensions in the Middle East, combined with looming production decisions from OPEC+, weighed on benchmarks during midday trading.

Microsoft and Ericsson Automate 5G Connectivity for Windows 11

Ericsson and Microsoft announced a partnership on Tuesday to integrate AI-driven 5G capabilities into Windows 11, streamlining how enterprise laptops connect to cellular networks. By merging Microsoft’s device management tools with Ericsson’s Enterprise 5G Connect platform, the collaboration aims to automate network switching and optimize connectivity for corporate fleets.

JFB Construction Shares Plunge 49% on $1.5B Xtend Drone Merger

JFB Construction shares cratered Tuesday after the Florida-based firm announced a $1.5 billion all-stock merger with Israeli drone manufacturer Xtend. The deal, expected to close by mid-2026, will pivot the construction company toward the defense sector under the new name Xtend AI Robotics.

Canaccord Genuity Shares Surge on Record Mining Activity

Canaccord Genuity Group Inc. shares climbed Tuesday after the financial services firm reported third-quarter earnings and revenue that significantly outpaced analyst expectations. Driven by a resurgence in Australian metals and mining activity and record-high gold prices, the company’s profit more than doubled year-over-year, signaling a robust recovery in global capital markets.

Gemini C-Suite Exodus Follows Job Cuts and Ballooning Losses

Gemini Space Station announced the immediate departure of three top executives on Tuesday, including its finance and operations chiefs, less than two weeks after slashing a quarter of its workforce. The leadership shakeup at the Winklevoss-founded crypto exchange arrives as the firm projects a wider-than-expected $267 million adjusted loss for fiscal 2025, signaling a period of intense contraction for the embattled platform.

Fund Managers Pivot to Europe as US Tech AI Costs Balloon

Institutional investors are rapidly souring on U.S. equities, shifting capital toward Europe as concerns mount over the unsustainable capital expenditures of Silicon Valley’s tech giants. According to the latest Bank of America survey, the net proportion of fund managers bearish on Wall Street surged to 22% in February, a sharp climb from just 3% the previous month.

Palo Alto Networks Eyes Profit Growth Amid Aggressive M&A Strategy

Palo Alto Networks is expected to report a surge in fiscal second-quarter profit on Tuesday, with analysts forecasting earnings of $343.8 million as the cybersecurity leader doubles down on its strategy to consolidate the market. Despite a recent slump in software valuations, the company is betting on a high-stakes "platformization" model to integrate new AI-driven capabilities and secure its dominance.

Uber and Life360 Deepen Ties with Integrated Family Safety Features

Uber Technologies and Life360 have announced an expanded partnership that will allow users to link their accounts, streamlining how parents and teens coordinate rides. The integration, set to launch later this year, aims to provide real-time updates and enhanced visibility for families using the ride-hailing platform.

NeoVolta Shares Slide 12% as Widening Q2 Loss Eclipses Revenue Growth

NeoVolta stock dropped 12% to $3.28 after the energy technology firm reported a second-quarter loss that ballooned to $5.5 million, even as revenue saw a fourfold increase. While the company successfully scaled its distribution footprint, the bottom line was weighed down by significant stock-based compensation and non-operating charges.

Food Stocks Tumble as General Mills Warns of Strained Consumers

Shares of major consumer food companies plummeted after General Mills lowered its fiscal-year projections, citing a sharp decline in consumer sentiment that is stifling sales volumes. Speaking at the Consumer Analyst Group of New York conference, CEO Jeff Harmening warned that persistent inflation and reduced government benefits are forcing middle- and lower-income households to drastically pull back on spending.

Polaryx Therapeutics Jumps 66% on Phase 2 Trial Expansion Plans

Polaryx Therapeutics shares surged 66% to $4.01 after the biotechnology firm appointed a contract research organization to lead a Phase 2 clinical trial for its lead candidate, PLX-200. The study will evaluate the drug’s safety and efficacy across four distinct lysosomal storage disorders.

Knife River Stock Surges on Earnings Beat and Upgraded Outlook

Knife River shares jumped 12% on Tuesday morning after the construction materials provider reported fourth-quarter earnings and a long-term revenue forecast that cleared Wall Street expectations. The company posted a net profit of $32 million, fueled by double-digit revenue growth across its core materials and contracting divisions.